Skip to main content
Erschienen in: Inflammation 2-3/2005

01.06.2005

Oral Temperature in Daily Life. A New Look in the Era of Microinflammation

verfasst von: O. Rogowski, I. Shapira, S. Toker, A. Shirom, S. Melamed, S. Berliner

Erschienen in: Inflammation | Ausgabe 2-3/2005

Einloggen, um Zugang zu erhalten

Abstract

It has been repeatedly shown that apparently healthy individuals and those with atherothrombotic risk factors harbor a low grade subclinical internal inflammation (microinflammation). This low grade acute phase response is relevant for the presence of atherothrombosis and future vascular events. Since these events are associated with a febrile response, we thought that it is relevant to clarify whether the microinflammatory response has an influence on the oral temperature. Included were 2,340 men and 1,280 women in whom the white blood cell count (WBCC) and differential, as well as the erythrocyte sedimentation rate (ESR), quantitative fibrinogen and high sensitivity C-reactive protein (hs-CRP) were determined in addition to the oral temperature in quiescent conditions. There was no association between these inflammatory biomarkers, except from a weak association with the absolute number of polymorphonuclear leukocytes. This association could be, however, related to the stress of the examination itself. Thus, it is unlikely that the microinflammatory response in daily life is associated, to a significant degree, with an enhanced oral temperature. The results are relevant for the findings of elevated oral temperature during conditions of acute ischemia/infarction where the temperature is probably related to the event itself and not to the patient's background microinflammation.
Literatur
1.
Zurück zum Zitat Viles-Gonzalez, J. F., V. Fuster, and J. J. Badimon. 2004. Atherothrombosis: a widespread disease with unpredictable and life-threatening consequences. Eur. Heart. J. 25:1197–1207.PubMedCrossRef Viles-Gonzalez, J. F., V. Fuster, and J. J. Badimon. 2004. Atherothrombosis: a widespread disease with unpredictable and life-threatening consequences. Eur. Heart. J. 25:1197–1207.PubMedCrossRef
2.
Zurück zum Zitat Ridker P. M. 2003. Cardiology Patient Page. C-reactive protein: a simple test to help predict risk of heart attack and stroke. Circulation. 108:e81–e85.PubMedCrossRef Ridker P. M. 2003. Cardiology Patient Page. C-reactive protein: a simple test to help predict risk of heart attack and stroke. Circulation. 108:e81–e85.PubMedCrossRef
3.
Zurück zum Zitat Libby P., and P. M. Ridker. 2004. Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. Am. J. Med. 116:9S–16S.PubMedCrossRef Libby P., and P. M. Ridker. 2004. Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. Am. J. Med. 116:9S–16S.PubMedCrossRef
4.
Zurück zum Zitat Biasucci L. M. 2004. CDC/AHA workshop on markers of inflammation and cardiovascular disease: application to clinical and public health practice: clinical use of inflammatory markers in patients with cardiovascular diseases: a background paper. Circulation 110:e560–e567.PubMedCrossRef Biasucci L. M. 2004. CDC/AHA workshop on markers of inflammation and cardiovascular disease: application to clinical and public health practice: clinical use of inflammatory markers in patients with cardiovascular diseases: a background paper. Circulation 110:e560–e567.PubMedCrossRef
5.
Zurück zum Zitat Hansson G. K. 2005. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352:1685–1695.PubMedCrossRef Hansson G. K. 2005. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352:1685–1695.PubMedCrossRef
6.
Zurück zum Zitat Libby P., P. M. Ridker, and A. Maseri. 2002. Inflammation and atherosclerosis. Circulation 105:1135–1143.PubMedCrossRef Libby P., P. M. Ridker, and A. Maseri. 2002. Inflammation and atherosclerosis. Circulation 105:1135–1143.PubMedCrossRef
7.
Zurück zum Zitat Ridker P. M. 2002. On evolutionary biology, inflammation, infection, and the causes of atherosclerosis. Circulation 105:2–4.PubMed Ridker P. M. 2002. On evolutionary biology, inflammation, infection, and the causes of atherosclerosis. Circulation 105:2–4.PubMed
8.
9.
Zurück zum Zitat Dinarello C. A. 1996. Thermoregulation and the pathogenesis of fever. Infect. Dis. Clin. North. Am. 10:433–449.PubMedCrossRef Dinarello C. A. 1996. Thermoregulation and the pathogenesis of fever. Infect. Dis. Clin. North. Am. 10:433–449.PubMedCrossRef
10.
Zurück zum Zitat Bernheim H. A., L. H. Block, and E. Atkins. 1979. Fever: pathogenesis, pathophysiology, and purpose. Ann. Intern. Med. 91:261–270.PubMed Bernheim H. A., L. H. Block, and E. Atkins. 1979. Fever: pathogenesis, pathophysiology, and purpose. Ann. Intern. Med. 91:261–270.PubMed
11.
Zurück zum Zitat Roy M. K., and A. Ray. 2004. Effect of body temperature on mortality of acute stroke. J. Assoc. Phys. India. 52:959–961. Roy M. K., and A. Ray. 2004. Effect of body temperature on mortality of acute stroke. J. Assoc. Phys. India. 52:959–961.
12.
Zurück zum Zitat Rogowski O., S. Toker, I. Shapira, S. Melamed, A. Shirom, D. Zeltser, and S. Berliner. 2005. Values of high sensitivity C-reactive protein in each month of the year in apparently healthy individuals. Am. J. Cardiol. 95:152–155.PubMedCrossRef Rogowski O., S. Toker, I. Shapira, S. Melamed, A. Shirom, D. Zeltser, and S. Berliner. 2005. Values of high sensitivity C-reactive protein in each month of the year in apparently healthy individuals. Am. J. Cardiol. 95:152–155.PubMedCrossRef
13.
Zurück zum Zitat Rogowski O., I. Shapira, A. Zimran, D. Zeltser, D. Elstein, D. Attias, A. Bashkin, and S. Berliner. 2005. Automated system to detect low-grade underlying inflammatory profile: Gaucher disease as a model. Blood Cells Mol. Diseases 34:26–29.CrossRef Rogowski O., I. Shapira, A. Zimran, D. Zeltser, D. Elstein, D. Attias, A. Bashkin, and S. Berliner. 2005. Automated system to detect low-grade underlying inflammatory profile: Gaucher disease as a model. Blood Cells Mol. Diseases 34:26–29.CrossRef
14.
Zurück zum Zitat Berliner S., I. Shapira, S. Toker, S. Melamed, A. Shirom, and O. Rogowski. 2005. Benign hereditary leukopenia-neutropenia does not result from lack of low grade inflammation. A new look in the era of microinflammation. Blood Cells Mol. Diseases 34:135–140.CrossRef Berliner S., I. Shapira, S. Toker, S. Melamed, A. Shirom, and O. Rogowski. 2005. Benign hereditary leukopenia-neutropenia does not result from lack of low grade inflammation. A new look in the era of microinflammation. Blood Cells Mol. Diseases 34:135–140.CrossRef
15.
Zurück zum Zitat Cohen S., T. Tolshinsky, O. Rogowski, I. Shapira, K. Lachmi, M. Hirsch, E. Ben Assayag, M. Burke, V. Deutch, S. Berliner, P. Halpern, and J. Serov. 2003. Real time, control adjusted evaluation of intensity of the inflammatory response. J. Inform. Techn. Healthcare 1:195–207. Cohen S., T. Tolshinsky, O. Rogowski, I. Shapira, K. Lachmi, M. Hirsch, E. Ben Assayag, M. Burke, V. Deutch, S. Berliner, P. Halpern, and J. Serov. 2003. Real time, control adjusted evaluation of intensity of the inflammatory response. J. Inform. Techn. Healthcare 1:195–207.
16.
Zurück zum Zitat International committee for standardization in hematology. 1965. Recommendation of measurement of erythrocyte sedimentation rate of human blood. Immunochemistry 2:235–254.CrossRef International committee for standardization in hematology. 1965. Recommendation of measurement of erythrocyte sedimentation rate of human blood. Immunochemistry 2:235–254.CrossRef
17.
Zurück zum Zitat Clauss A. 1957. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta. Haematol. Basel. 17:237–246.CrossRef Clauss A. 1957. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta. Haematol. Basel. 17:237–246.CrossRef
18.
Zurück zum Zitat Rifai N., R. P. Tracy, and P. M. Ridker. 1999. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin. Chem. 45:2136–2141.PubMed Rifai N., R. P. Tracy, and P. M. Ridker. 1999. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin. Chem. 45:2136–2141.PubMed
19.
Zurück zum Zitat Gabay C., and I. Kushner. 1999. Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 11:448–454.CrossRef Gabay C., and I. Kushner. 1999. Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 11:448–454.CrossRef
20.
Zurück zum Zitat Kammersgaard L. P., H. S. Jorgensen, J. A. Rungby, J. Reith, H. Nakayama, U. J. Weber, J. Houth, and T. S. Olsen. 2002. Admission body temperature predicts long-term mortality after acute stroke: The Copenhagen Stroke Study. Stroke 33:1759–1762.PubMedCrossRef Kammersgaard L. P., H. S. Jorgensen, J. A. Rungby, J. Reith, H. Nakayama, U. J. Weber, J. Houth, and T. S. Olsen. 2002. Admission body temperature predicts long-term mortality after acute stroke: The Copenhagen Stroke Study. Stroke 33:1759–1762.PubMedCrossRef
21.
Zurück zum Zitat Christensen H., G. Boysen, H. H. Johannesen, E. Christensen, and K. Bendtzen. 2002. Deteriorating ischaemic stroke. cytokines, soluble cytokine receptors, ferritin, systemic blood pressure, body temperature, blood glucose, diabetes, stroke severity, and CT infarction-volume as predictors of deteriorating ischaemic stroke. J. Neurol. Sci. 201:1–7.PubMedCrossRef Christensen H., G. Boysen, H. H. Johannesen, E. Christensen, and K. Bendtzen. 2002. Deteriorating ischaemic stroke. cytokines, soluble cytokine receptors, ferritin, systemic blood pressure, body temperature, blood glucose, diabetes, stroke severity, and CT infarction-volume as predictors of deteriorating ischaemic stroke. J. Neurol. Sci. 201:1–7.PubMedCrossRef
22.
Zurück zum Zitat Castellanos M., R. Leira, J. Tejada, A. Gil-Peralta, A. Davalos, and J. Castillo. 2005. Predictors of good outcome in medium to large spontaneous supratentorial intracerebral haemorrhages. J. Neurol. Neurosurg. Psychiatry 76:691–695.PubMedCrossRef Castellanos M., R. Leira, J. Tejada, A. Gil-Peralta, A. Davalos, and J. Castillo. 2005. Predictors of good outcome in medium to large spontaneous supratentorial intracerebral haemorrhages. J. Neurol. Neurosurg. Psychiatry 76:691–695.PubMedCrossRef
23.
Zurück zum Zitat Leira R., A. Davalos, Y. Silva, A. Gil-Peralta, J. Tejada, M. Garcia, and J. Castillo. 2004. Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors. Neurology 63:461–467.PubMed Leira R., A. Davalos, Y. Silva, A. Gil-Peralta, J. Tejada, M. Garcia, and J. Castillo. 2004. Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors. Neurology 63:461–467.PubMed
24.
Zurück zum Zitat Nito C., T. Kamiya, M. Ueda, T. Arii, and Y. Katayama. 2004. Mild hypothermia enhances the neuroprotective effects of FK506 and expands its therapeutic window following transient focal ischemia in rats. Brain Res. 1008:179–185.PubMedCrossRef Nito C., T. Kamiya, M. Ueda, T. Arii, and Y. Katayama. 2004. Mild hypothermia enhances the neuroprotective effects of FK506 and expands its therapeutic window following transient focal ischemia in rats. Brain Res. 1008:179–185.PubMedCrossRef
25.
Zurück zum Zitat del Brutto O. H. 2004. Relationship between body temperature and prognosis, and neuroprotective effect of hypothermia in acute stroke patients. Rev. Neurol. 38:1050–1055.PubMed del Brutto O. H. 2004. Relationship between body temperature and prognosis, and neuroprotective effect of hypothermia in acute stroke patients. Rev. Neurol. 38:1050–1055.PubMed
26.
Zurück zum Zitat Steinberg G. K., C. S. Ogilvy, L. M. Shuer, E. S. Connolly Jr., R. A. Solomon, A. Lam, N. F. Kassell, C. J. Baker, S. L. Giannotta, K. M. Cockroft, T. E. Bell-Stephens, and R. L. Allgren. 2004. Comparison of endovascular and surface cooling during unruptured cerebral aneurysm repair. Neurosurgery 55:307–314.PubMedCrossRef Steinberg G. K., C. S. Ogilvy, L. M. Shuer, E. S. Connolly Jr., R. A. Solomon, A. Lam, N. F. Kassell, C. J. Baker, S. L. Giannotta, K. M. Cockroft, T. E. Bell-Stephens, and R. L. Allgren. 2004. Comparison of endovascular and surface cooling during unruptured cerebral aneurysm repair. Neurosurgery 55:307–314.PubMedCrossRef
27.
Zurück zum Zitat Audebert H. J., M. M. Rott, T. Eck, and R. L. Haberl. 2004. Systemic inflammatory response depends on initial stroke severity but is attenuated by successful thrombolysis. Stroke 35:2128–2133.PubMedCrossRef Audebert H. J., M. M. Rott, T. Eck, and R. L. Haberl. 2004. Systemic inflammatory response depends on initial stroke severity but is attenuated by successful thrombolysis. Stroke 35:2128–2133.PubMedCrossRef
28.
Zurück zum Zitat De Georgia M. A., D. W. Krieger, A. bou-Chebl, T. G. Devlin, M. Jauss, S. M. Davis, W. J. Koroshetz, G. Rordorf, and S. Warach. 2004. Cooling for Acute Ischemic Brain Damage. COOL AID.: a feasibility trial of endovascular cooling. Neurology 63:312–317.PubMed De Georgia M. A., D. W. Krieger, A. bou-Chebl, T. G. Devlin, M. Jauss, S. M. Davis, W. J. Koroshetz, G. Rordorf, and S. Warach. 2004. Cooling for Acute Ischemic Brain Damage. COOL AID.: a feasibility trial of endovascular cooling. Neurology 63:312–317.PubMed
29.
Zurück zum Zitat van Breda E. J., H. B. van der Worp, H. M. van Gemert, A. Algra, L. J. Kappelle, J. van Gijn, P. J. Koudstaal, and D. W. Dippel. 2004. Reduction of body temperature with paracetamol in patients with acute stroke: randomised clinical trials are needed. Cerebrovasc. Dis. 18:350.PubMedCrossRef van Breda E. J., H. B. van der Worp, H. M. van Gemert, A. Algra, L. J. Kappelle, J. van Gijn, P. J. Koudstaal, and D. W. Dippel. 2004. Reduction of body temperature with paracetamol in patients with acute stroke: randomised clinical trials are needed. Cerebrovasc. Dis. 18:350.PubMedCrossRef
30.
Zurück zum Zitat Slotboom J., C. Kiefer, C. Brekenfeld, C. Ozdoba, L. Remonda, K. Nedeltchev, M. Arnold, H. Mattle, and G. Schroth. 2004. Locally induced hypothermia for treatment of acute ischaemic stroke: a physical feasibility study. Neuroradiology 46:923–934.PubMedCrossRef Slotboom J., C. Kiefer, C. Brekenfeld, C. Ozdoba, L. Remonda, K. Nedeltchev, M. Arnold, H. Mattle, and G. Schroth. 2004. Locally induced hypothermia for treatment of acute ischaemic stroke: a physical feasibility study. Neuroradiology 46:923–934.PubMedCrossRef
31.
Zurück zum Zitat Coller B. S., 2005. Leukocytosis and ischemic vascular disease morbidity and mortality: is it time to intervene? Arterioscler. Thromb. Vasc. Biol. 25:658–670.PubMedCrossRef Coller B. S., 2005. Leukocytosis and ischemic vascular disease morbidity and mortality: is it time to intervene? Arterioscler. Thromb. Vasc. Biol. 25:658–670.PubMedCrossRef
32.
Zurück zum Zitat Erikssen G., K. Liestol, J. V. Bjornholt, H. Stormorken, E. Thaulow, and J. Erikssen. 2000. Erythrocyte sedimentation rate: a possible marker of atherosclerosis and a strong predictor of coronary heart disease and mortality. Eur. Heart. J. 21:1614–1620.PubMedCrossRef Erikssen G., K. Liestol, J. V. Bjornholt, H. Stormorken, E. Thaulow, and J. Erikssen. 2000. Erythrocyte sedimentation rate: a possible marker of atherosclerosis and a strong predictor of coronary heart disease and mortality. Eur. Heart. J. 21:1614–1620.PubMedCrossRef
33.
Zurück zum Zitat Maresca G., A. Di Blasio, R. Marchioli, and G. Di Minno. 1999. Measuring plasma fibrinogen to predict stroke and myocardial infarction: an update. Arterioscler. Thromb. Vasc. Biol. 19:1368–1377.PubMed Maresca G., A. Di Blasio, R. Marchioli, and G. Di Minno. 1999. Measuring plasma fibrinogen to predict stroke and myocardial infarction: an update. Arterioscler. Thromb. Vasc. Biol. 19:1368–1377.PubMed
34.
Zurück zum Zitat Labarrere C. A., and G. P. Zaloga. 2004. C-reactive protein: from innocent bystander to pivotal mediator of atherosclerosis. Am. J. Med. 117:499–507.PubMedCrossRef Labarrere C. A., and G. P. Zaloga. 2004. C-reactive protein: from innocent bystander to pivotal mediator of atherosclerosis. Am. J. Med. 117:499–507.PubMedCrossRef
Metadaten
Titel
Oral Temperature in Daily Life. A New Look in the Era of Microinflammation
verfasst von
O. Rogowski
I. Shapira
S. Toker
A. Shirom
S. Melamed
S. Berliner
Publikationsdatum
01.06.2005
Erschienen in
Inflammation / Ausgabe 2-3/2005
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-006-9006-y

Weitere Artikel der Ausgabe 2-3/2005

Inflammation 2-3/2005 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.